Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote Monitoring

NATerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 6, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Heart Failure
Interventions
DEVICE

Biobeat Wrist Watch

Standard of care procedures and therapies for managing heart failure will be carried out according to each investigator's standard procedures. In addition, participants will be provided with a Biobeat wrist watch for continuous measurement and reporting of blood pressure data and with a smartphone to report weight.

OTHER

Standard of Care

Standard of care procedures and therapies for managing heart failure will be carried out according to each investigator's standard procedures.

Trial Locations (8)

22042

Inova Heart and Vascular Institute, Falls Church

27710

Duke University Medical Center, Durham

37388

Tennessee Center for Clinical Trials, a division of Cardiology and Vascular Associates PLLC, Tullahoma

37404

Diagnostic Cardiology Group, Chattanooga

50702

MercyOne Northeast Iowa Family Medicine and Residency, Waterloo

06520

Yale New Haven Hospital, New Haven

06905

Cardiology Associates of Fairfield County, PC, Stamford

08043

Virtua Health Inc., Voorhees Township

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY